Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Biotech Portfolio Update: 2012 Summary And 2013 Outlook
Biotech Portfolio Update: 2012 Summary And 2013 Outlook
Biotech Portfolio Update: 2012 Summary And 2013 Outlook
Submitted by
admin
on December 24, 2012 - 10:44am
Source:
Seeking Alpha
News Tags:
Arqule
Array Biopharma
Celldex
Aveo Pharmaceutical
Curis
Exelixis
MorphoSys
Genmab
Novartis
Incyte
Seattle Genetics
YM BioSciences
Headline:
Biotech Portfolio Update: 2012 Summary And 2013 Outlook
Do Not Allow Advertisers to Use My Personal information
